# Golden Minerals Co: financial statements, quarterly

AUMN · OTC · CIK 1011509 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aumn.md) · [Financials](/companies/aumn/financials.md) · [Filings](/companies/aumn/filings.md) · [Insiders](/companies/aumn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aumn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,268](/filings/0001558370-23-018635.md) | [4,585 d](/filings/0001558370-24-003526.md) | [4,217](/filings/0001558370-24-008021.md) | [4,973](/filings/0001558370-24-012118.md) | [2,512](/filings/0001558370-24-015859.md) | [300 d](/filings/0001558370-24-003526.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $k | [4,374](/filings/0001558370-23-018635.md) | [4,203 d](/filings/0001558370-24-003526.md) | [4,046](/filings/0001558370-24-008021.md) | [3,859](/filings/0001558370-24-012118.md) | [3,320](/filings/0001558370-24-015859.md) | [1,133 d](/filings/0001558370-24-003526.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(2,894)](/filings/0001558370-23-018635.md) | [(3,995) d](/filings/0001558370-24-003526.md) | [(2,830)](/filings/0001558370-24-008021.md) | [(1,113)](/filings/0001558370-24-012118.md) | [(2,353)](/filings/0001558370-24-015859.md) | [(219) d](/filings/0001558370-25-004847.md) | [(1,211)](/filings/0001558370-25-008033.md) | [(1,449)](/filings/0001176256-25-000069.md) | [(582)](/filings/0001558370-24-015859.md) | [(686) d](/filings/0001558370-25-004847.md) | [(860)](/filings/0001558370-25-008033.md) | [(933)](/filings/0001176256-25-000069.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [(46.0)](/filings/0001558370-23-018635.md) | [178 d](/filings/0001558370-24-003526.md) | [51.0](/filings/0001558370-23-008916.md) | [(51.0)](/filings/0001558370-23-014059.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(2,697)](/filings/0001558370-23-018635.md) | [(4,080) d](/filings/0001558370-24-003526.md) | [(3,266)](/filings/0001558370-24-015859.md) | [(1,488)](/filings/0001558370-24-015859.md) | [(3,177)](/filings/0001558370-24-015859.md) | [(1,297) d](/filings/0001558370-25-004847.md) | [(4,565)](/filings/0001176256-25-000069.md) | [(2,747)](/filings/0001176256-25-000069.md) | [199](/filings/0001558370-24-015859.md) | [(487) d](/filings/0001558370-25-004847.md) | [(1,239)](/filings/0001176256-25-000069.md) | [(840)](/filings/0001176256-25-000069.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.40)](/filings/0001558370-23-018635.md) | not reported | [(0.47)](/filings/0001558370-24-008021.md) | [(0.21)](/filings/0001558370-24-012118.md) | [(0.38)](/filings/0001558370-24-015859.md) | not reported | [(0.32)](/filings/0001558370-25-008033.md) | [(0.19)](/filings/0001176256-25-000069.md) | [0.01](/filings/0001558370-24-015859.md) | not reported | [(0.08)](/filings/0001558370-25-008033.md) | [(0.06)](/filings/0001176256-25-000069.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.5](/filings/0001558370-22-017222.md) | [4.0](/filings/0001558370-24-003526.md) | [2.0](/filings/0001558370-23-008916.md) | [3.4](/filings/0001558370-23-014059.md) | [1.6](/filings/0001558370-23-018635.md) | [3.8](/filings/0001558370-25-004847.md) | [2.4](/filings/0001558370-24-008021.md) | [1.4](/filings/0001558370-24-012118.md) | [1.8](/filings/0001558370-24-015859.md) | [3.2](/filings/0001176256-25-000069.md) | [3.5](/filings/0001558370-25-008033.md) | [2.5](/filings/0001176256-25-000069.md) |
| Current assets | $m | [11.3](/filings/0001558370-22-017222.md) | [8.0](/filings/0001558370-24-003526.md) | [6.8](/filings/0001558370-23-008916.md) | [8.6](/filings/0001558370-23-014059.md) | [5.9](/filings/0001558370-23-018635.md) | [8.7](/filings/0001558370-25-004847.md) | [5.3](/filings/0001558370-24-008021.md) | [2.5](/filings/0001558370-24-012118.md) | [2.5](/filings/0001558370-24-015859.md) | [3.9](/filings/0001176256-25-000069.md) | [4.0](/filings/0001558370-25-008033.md) | [2.7](/filings/0001176256-25-000069.md) |
| Total assets | $m | [18.5](/filings/0001558370-23-018635.md) | [14.9](/filings/0001558370-24-003526.md) | [14.9](/filings/0001558370-24-008021.md) | [15.2](/filings/0001558370-24-012118.md) | [12.3](/filings/0001558370-24-015859.md) | [14.9](/filings/0001558370-25-004847.md) | [11.4](/filings/0001558370-24-008021.md) | [6.1](/filings/0001558370-24-012118.md) | [6.1](/filings/0001558370-24-015859.md) | [4.8](/filings/0001176256-25-000069.md) | [4.9](/filings/0001558370-25-008033.md) | [3.7](/filings/0001176256-25-000069.md) |
| Current liabilities | $m | [5.0](/filings/0001558370-22-017222.md) | [4.3](/filings/0001558370-24-003526.md) | [5.3](/filings/0001558370-23-008916.md) | [5.4](/filings/0001558370-23-014059.md) | [5.6](/filings/0001558370-23-018635.md) | [5.7](/filings/0001558370-25-004847.md) | [6.5](/filings/0001558370-24-008021.md) | [4.8](/filings/0001558370-24-012118.md) | [4.5](/filings/0001558370-24-015859.md) | [3.6](/filings/0001176256-25-000069.md) | [4.9](/filings/0001558370-25-008033.md) | [4.3](/filings/0001176256-25-000069.md) |
| Total liabilities | $m | [8.9](/filings/0001558370-22-017222.md) | [8.5](/filings/0001558370-24-003526.md) | [9.5](/filings/0001558370-23-008916.md) | [9.6](/filings/0001558370-23-014059.md) | [9.8](/filings/0001558370-23-018635.md) | [9.8](/filings/0001558370-25-004847.md) | [10.7](/filings/0001558370-24-008021.md) | [8.0](/filings/0001558370-24-012118.md) | [7.8](/filings/0001558370-24-015859.md) | [6.9](/filings/0001176256-25-000069.md) | [8.2](/filings/0001558370-25-008033.md) | [7.7](/filings/0001176256-25-000069.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [9.6](/filings/0001558370-23-018635.md) | [6.5](/filings/0001558370-25-004847.md) | [4.1](/filings/0001558370-24-015859.md) | [5.6](/filings/0001558370-24-015859.md) | [2.5](/filings/0001558370-24-015859.md) | [5.1](/filings/0001176256-25-000069.md) | [0.6](/filings/0001176256-25-000069.md) | [(2.0)](/filings/0001176256-25-000069.md) | [(1.7)](/filings/0001558370-24-015859.md) | [(2.1)](/filings/0001176256-25-000069.md) | [(3.3)](/filings/0001176256-25-000069.md) | [(4.0)](/filings/0001176256-25-000069.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,769) d](/filings/0001558370-23-018635.md) | [(3,256) d](/filings/0001558370-24-003526.md) | [(2,679)](/filings/0001558370-24-008021.md) | [(1,620) d](/filings/0001558370-24-012118.md) | [(2,258) d](/filings/0001558370-24-015859.md) | [(3,355) d](/filings/0001558370-25-004847.md) | [(1,331)](/filings/0001558370-25-008033.md) | [(3,490) d](/filings/0001176256-25-000069.md) | [(777) d](/filings/0001558370-24-015859.md) | [(2,139) d](/filings/0001558370-25-004847.md) | [354](/filings/0001558370-25-008033.md) | [(2,776) d](/filings/0001176256-25-000069.md) |
| Capital expenditure | $k | [19.0](/filings/0001558370-23-018635.md) | [6.0 d](/filings/0001558370-24-003526.md) | [5.0](/filings/0001558370-23-008916.md) | [0.0 d](/filings/0001558370-23-014059.md) | not reported | not reported | not reported | [28.0](/filings/0001558370-24-012118.md) | [(1.0) d](/filings/0001558370-24-015859.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q2 FY2018 (2018-06-30) | Q3 FY2018 (2018-09-30) | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q3 FY2020 (2020-09-30) | Q3 FY2021 (2021-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.8](/filings/0001104659-12-035299.md) | [15.0](/filings/0001104659-12-055975.md) | [20.0](/filings/0001104659-12-076094.md) | [35.5](/filings/0001104659-12-035299.md) | [35.5](/filings/0001104659-12-055975.md) | [36.3](/filings/0001104659-12-076094.md) | [97.2](/filings/0001558370-19-007291.md) | [99.5](/filings/0001558370-19-010853.md) | [102](/filings/0001558370-19-007291.md) | [105](/filings/0001558370-19-010853.md) | [143](/filings/0001558370-21-014352.md) | [175](/filings/0001558370-21-014352.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,053,048 at 2025-08-13, from the cover of the [10-Q filed 2025-08-14](/filings/0001176256-25-000069.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.